Rabies Immune Globulin (Human)
Establishment time : 1978
website : www.grifols.com
Main Product : Rabies Immune Globulin (Human)
Company Profile
Grifols is a global healthcare company that specializes in the production of plasma-derived therapies, including rabies immune globulin. With a history dating back to 1940, Grifols has established itself as a leader in the industry, providing high-quality products to patients worldwide.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Rabies Immune Globulin (Equine)
Establishment time : 1997
website : www.grifols.com
Main Product : Rabies Immune Globulin (Equine)
Company Profile
Grifols is a global healthcare company with a history of more than 75 years dedicated to improving the health and well-being of people around the world. The company specializes in producing plasma-derived medicines, including the Rabies Immune Globulin (Equine), which is used for post-exposure prophylaxis against rabies. Grifols is known for its commitment to innovation, quality, and patient care.
BayRab
Establishment time : 1967
website : www.bayrab.com
Main Product : Rabies vaccine
Company Profile
BayRab is a leading manufacturer of rabies vaccine, established in 1967. Our products are distributed globally and we face strong competition in the market. Visit our website at www.bayrab.com for more information.
HyperRab
Establishment time : HyperRab is a leading biopharmaceutical company specializing in the production of rabies vaccines and immunoglobulins.
website :
Main Product : With a global presence, HyperRab serves markets all over the world, providing life-saving treatments for rabies.
Company Profile
Overall, HyperRab is dedicated to saving lives and preventing the spread of rabies through their advanced vaccine technologies.
Kedrab
Establishment time : Kedrab is a leading manufacturer of industrial cleaning equipment and supplies.
website :
Main Product : Our products are known for their high quality and durability.
Company Profile
Kedrab is dedicated to providing reliable and efficient cleaning solutions for businesses worldwide.
HyperRab S/D
Establishment time : HyperRab S/D is a leading manufacturer of rabies immune globulin.
website :
Main Product : With a medium-sized team, HyperRab S/D serves markets worldwide.
Company Profile
Visit www.hyperrab.com for more information about the company and its products.
Imogam Rabies
Establishment time : Imogam Rabies is a trusted provider of rabies vaccine worldwide.
website :
Main Product : Imogam Rabies is known for its high-quality vaccine that is effective in preventing rabies infection.
Company Profile
Choose Imogam Rabies for trusted protection against rabies.
Imogam Rabies Pasteurized
Establishment time : Imogam Rabies Pasteurized is a crucial component in preventing and treating rabies infections.
website :
Main Product : With a large presence in the global market, the company is a trusted supplier of rabies vaccines.
Company Profile
As a leading provider of rabies vaccines, the company continues to innovate and improve their products to better protect public health.
RabAvert
Establishment time : RabAvert is a leading manufacturer of rabies vaccines.
website :
Main Product : RabAvert's main product is its rabies vaccine, which is used to prevent the deadly virus.
Company Profile
With a commitment to quality and innovation, RabAvert remains at the forefront of rabies prevention.
July 19, 2024
